12:00 AM
May 14, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Phosphatidylinositol 4-kinase catalytic β (PI4KB; PI4KIIIβ)

Infectious disease

INDICATION: Viral infection

In vitro studies suggest inhibitors of PI4KB could help treat RNA virus infections. Chemical synthesis and in vitro testing of pyrazolopyrimidine analogs identified multiple compounds that...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >